Schedule 13G ownership disclosure

CELLYAN BIOTECHNOLOGY CO LTD

Ordinary Shares, $0.001 par value · CUSIP: G6365B104

Event date: 2025-03-31

Filing-level shares
617,850.00
Percent of class
5.62%
  • Pacific Health Century International Group

    Shares: 617,850.00 · Class: 5.62%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-051435
Form type
SCHEDULE 13G
Filer
Cellyan Biotechnology Co., Ltd
CIK
CIK 2007702
Filed
Jun 05, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub